OtherInvited Perspectives
Brain access of monoclonal antibodies as imaged and quantified by 89Zr-antibody-PET: perspectives for treatment of brain diseases
Sophie E.M. Veldhuijzen van Zanten, Philip C. De Witt Hamer and Guus A.M.S. van Dongen
Journal of Nuclear Medicine February 2019, jnumed.118.220939; DOI: https://doi.org/10.2967/jnumed.118.220939
Sophie E.M. Veldhuijzen van Zanten
1 Amsterdam UMC, Vrije Universiteit Amsterdam, department of Pediatrics;
Philip C. De Witt Hamer
2 Amsterdam UMC, Vrije Universiteit Amsterdam, department of Neurosurgery;
Guus A.M.S. van Dongen
3 Amsterdam UMC, Vrije Universiteit Amsterdam, department of Radiology & Nuclear Medicine
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
Brain access of monoclonal antibodies as imaged and quantified by 89Zr-antibody-PET: perspectives for treatment of brain diseases
Sophie E.M. Veldhuijzen van Zanten, Philip C. De Witt Hamer, Guus A.M.S. van Dongen
Journal of Nuclear Medicine Feb 2019, jnumed.118.220939; DOI: 10.2967/jnumed.118.220939
Brain access of monoclonal antibodies as imaged and quantified by 89Zr-antibody-PET: perspectives for treatment of brain diseases
Sophie E.M. Veldhuijzen van Zanten, Philip C. De Witt Hamer, Guus A.M.S. van Dongen
Journal of Nuclear Medicine Feb 2019, jnumed.118.220939; DOI: 10.2967/jnumed.118.220939